Sequential allocation to balance prognostic factors in a psychiatric clinical trial

Clinics

Volumn 64, Issue 6, 2009, Pages 511-518

  Fossaluza, Victor ^a   Diniz, Juliana Belo ^a   Pereira, Basilio de Bragança ^b   Miguel, Eurípedes Constantino ^a   Pereira, Carlos Alberto de Bragança ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Aitchison's compositional distance; Clinical research; Randomization

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; OBSESSIVE COMPULSIVE DISORDER; PATIENT SELECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PATIENT SELECTION; PROGNOSIS; SAMPLE SIZE;

EID: 68949144534     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000600005     Document Type: Article

References (18)

1. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive- compulsive disorder. Clin Psychol Rev. 2004;241011-30.
2. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622-32.
3. Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M. An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opin Pharmacother. 2007;8:563-83.
4. Lachin JM. Statistical properties of randomization in clinical trials. Controlled Clin Trials. 1988;9:289-311.
5. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz R. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19-26.
6. Pocock SJ, Simon R. Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial. Biometrics. 1975;31:103-15.
7. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443-53.
8. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials: a review. Controlled Clinical Trials. 2002;23:662-74.
9. Pocock SJ, Assmann SE, Enos LE, Kasten, LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statist Med. 2002;21:2917-30.
10. Atkinson AC. Optimum Biased Coin Designs for Sequential Clinical- Trials with Prognostic Factors. Biometrika. 1982;69:61-7.
11. Aitchison J. Principal component analysis of compositional data. Biometrika. 1983;70:57-65.
12. Aitchison J. The Statistical Analysis of Compositional Data. London: Chapman & Hall;1986.
13. Aitchison J, Egozcue J. Compositional Data Analysis: Where Are We and Where Should We Be Heading. Mathematical Geology. 2005;37:829-50.
14. Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive- compulsive disorder response to clomipramine. J Clin Psychopharmacol. 1993;13:210-3.
15. De Haan E, Van Oppen P, Van Balkom AJ, Spinhoven P, Hooguin L, Van Dyck R. Prediction of outcome and early versus late improvement in OCD patients treated with cognitive-behaviour therapy and pharmacotherapy. Acta Psychiatr Scand. 1987;96:354-61.
16. Mataix-Cols D, Rauch S, Manzo PA, Jenike MA, Bayer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409-16.
17. Steketee G, Eisen J, Dyck I, Warshaw M, Rasmussen S. Predictors of course in Obsessive-Compulsive Disorder. Psychiatry Res. 1999;89:229-38.
18. Thomsen PH, Mikkelsen HU. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases. J Am Acad Child Adolesc Psychiatry. 1995;34:1432-40.